Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Pulmonary Hypertension, July 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 172 articles:
HTML format


 

Single Articles

  1. BAQIR M, Singam NS, DuBrock H
    Pulmonary hypertension in ANCA-associated vasculitis: a retrospective analysis.
    Sarcoidosis Vasc Diffuse Lung Dis. 2023;40:e2023020.
    PubMed    
    Abstract available

  2. WU XC, Liu Y, Bai ZP
    [Compound Tinglizi Decoction intervenes COPD-associated pulmonary hypertension through regulation of HMGB1-mediated pyroptosis and immune imbalance].
    Zhongguo Zhong Yao Za Zhi. 2023;48:3055-3065.
    PubMed    
    Abstract available

  3. ITO R, Yamashita J, Ikeda S, Nakajima Y, et al
    Predictors of procedural complications in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    J Cardiol. 2023 Jun 26:S0914-5087(23)00156-9. doi: 10.1016/j.jjcc.2023.
    PubMed    
    Abstract available

  4. MORALES-CANO D, Izquierdo-Garcia JL, Barreira B, Esquivel-Ruiz S, et al
    Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model.
    Front Pharmacol. 2023;14:1228923.
    PubMed    
    Abstract available

  5. DONG W, Ma L, Huang Q, Yang X, et al
    Gut microbiome alterations in pulmonary hypertension in highlanders and lowlanders.
    ERJ Open Res. 2023;9:00617-2022.
    PubMed    
    Abstract available

  6. FTIKOS P, Falara A, Rellia P, Leontiadis E, et al
    Monitoring of Levosimendan Administration in Patients with Pulmonary Hypertension Undergoing Cardiac Surgery and Effect of Two Different Dosing Schemes on Hemodynamic and Echocardiographic Parameters.
    Pharmaceuticals (Basel). 2023;16:815.
    PubMed    
    Abstract available

  7. NAKATA M, Yokota N, Uehara H, Tabata K, et al
    Congenital Isolated Unilateral Agenesis of Pulmonary Arteries with 3-Year Follow-Up after Initiation of Treatment.
    Medicina (Kaunas). 2023;59:1161.
    PubMed    
    Abstract available

  8. KEW EP, Caruso V, Grapsa J, Bosco P, et al
    Predictors of Outcome in Patients with Pulmonary Hypertension Undergoing Mitral and Tricuspid Valve Surgery.
    Medicina (Kaunas). 2023;59:1103.
    PubMed    
    Abstract available

  9. SKAFAR M, Ambrozic J, Toplisek J, Cvijic M, et al
    Role of Exercise Stress Echocardiography in Pulmonary Hypertension.
    Life (Basel). 2023;13:1385.
    PubMed    
    Abstract available

  10. TRUSHENKO NV, Suvorova OA, Nekludova GV, Levina IA, et al
    Predictors of Pulmonary Hypertension and Right Ventricular Dysfunction in Patients with Hypersensitivity Pneumonitis.
    Life (Basel). 2023;13:1348.
    PubMed    
    Abstract available

  11. JANSA P, Ambroz D, Aschermann M, Cerny V, et al
    Correction: Jansa et al. Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension. J. Clin. Med. 2022, 11, 6189.
    J Clin Med. 2023;12:3939.
    PubMed    
    Abstract available

  12. LIU R, Yuan T, Wang R, Gong D, et al
    Insights into Endothelin Receptors in Pulmonary Hypertension.
    Int J Mol Sci. 2023;24:10206.
    PubMed    
    Abstract available

  13. LTAIEF Z, Yerly P, Liaudet L
    Pulmonary Hypertension in Left Heart Diseases: Pathophysiology, Hemodynamic Assessment and Therapeutic Management.
    Int J Mol Sci. 2023;24:9971.
    PubMed    
    Abstract available

  14. SAVALE L, Kularatne M, Roche A, Pichon J, et al
    Management of Acutely Decompensated Pulmonary Hypertension.
    Semin Respir Crit Care Med. 2023 Jun 27. doi: 10.1055/s-0043-1770119.
    PubMed    
    Abstract available

  15. MATHEW R, Iacobas S, Huang J, Iacobas DA, et al
    Metabolic Deregulation in Pulmonary Hypertension.
    Curr Issues Mol Biol. 2023;45:4850-4874.
    PubMed    
    Abstract available

  16. LAMMI MR, Kolstad KD, Saketkoo LA, Khatri A, et al
    Endothelial biomarkers of systemic sclerosis-associated pulmonary hypertension.
    Arthritis Care Res (Hoboken). 2023 Jun 26. doi: 10.1002/acr.25180.
    PubMed    
    Abstract available

  17. HANUNA M, Pattathu J, Buech J, Kamla C, et al
    Case report: Central venous catheter thrombosis complicated by chronic thromboembolic disease/pulmonary hypertension in two children requiring parenteral nutrition.
    Front Cardiovasc Med. 2023;10:1198204.
    PubMed    
    Abstract available

  18. GOYAL A, Avery R, Cuttica MJ, Flaherty JD, et al
    Case report: Multimodality imaging of unusual coronary to pulmonary collaterals in chronic thromboembolic pulmonary hypertension.
    Front Cardiovasc Med. 2023;10:1204736.
    PubMed    
    Abstract available

  19. FABYAN KD, Chandel A, King CS
    Pulmonary Hypertension in Interstitial Lung Disease: Management Options to Move Beyond Supportive Care.
    Curr Pulmonol Rep. 2023 May 22:1-8. doi: 10.1007/s13665-023-00311.
    PubMed    
    Abstract available

  20. KJELLSTROM B, Runheim H, Beaudet A, Husberg M, et al
    Societal costs associated to chronic thromboembolic pulmonary hypertension: A study utilizing linked national registries.
    Pulm Circ. 2023;13:e12254.
    PubMed    
    Abstract available

  21. MITTAL A, Hossain A, Wang D, Khrais A, et al
    Role of Gastroesophageal Reflux Disease in Morbidity and Mortality for Patients Admitted With Pulmonary Hypertension.
    Cureus. 2023;15:e39431.
    PubMed    
    Abstract available

  22. TCHUENTE FOGUEM G, Teguede Keleko A
    Artificial intelligence applied in pulmonary hypertension: a bibliometric analysis.
    AI Ethics. 2023 Mar 7:1-31. doi: 10.1007/s43681-023-00267.
    PubMed    
    Abstract available

  23. KASAHARA T, Ogata T, Nakanishi N, Tomita S, et al
    Cavin-2 loss exacerbates hypoxia-induced pulmonary hypertension with excessive eNOS phosphorylation and protein nitration.
    Heliyon. 2023;9:e17193.
    PubMed    
    Abstract available

  24. COOK CM, Craddock VD, Ram AK, Abraham AA, et al
    HIV and Drug Use: A Tale of Synergy in Pulmonary Vascular Disease Development.
    Compr Physiol. 2023;13:4659-4683.
    PubMed    
    Abstract available

  25. JONE PN, Ivy DD, Hauck A, Karamlou T, et al
    Pulmonary Hypertension in Congenital Heart Disease: A Scientific Statement From the American Heart Association.
    Circ Heart Fail. 2023 Jun 26:e000080. doi: 10.1161/HHF.0000000000000080.
    PubMed    
    Abstract available

  26. LIU Y, Luo Y, Shi X, Lu Y, et al
    Role of KLF4/NDRG1/DRP1 axis in hypoxia-induced pulmonary hypertension.
    Biochim Biophys Acta Mol Basis Dis. 2023 Jun 23:166794.
    PubMed    
    Abstract available

  27. WANG EL, Zhang JJ, Luo FM, Fu MY, et al
    Cerebellin-2 promotes endothelial-mesenchymal transition in hypoxic pulmonary hypertension rats by activating NF-kappaB/HIF-1alpha/Twist1 pathway.
    Life Sci. 2023;328:121879.
    PubMed    
    Abstract available

  28. WANG J, Ma YR, Chang YE, Duo DL, et al
    Preventive effect of LCZ696 on hypoxic pulmonary hypertension in rats via regulating the PI3K/AKT signaling pathway.
    Pulm Pharmacol Ther. 2023 Jun 22:102229. doi: 10.1016/j.pupt.2023.102229.
    PubMed    
    Abstract available

  29. ZHANG H, Kan J, Zhang J, Xie D, et al
    3-Year Outcome in Patients With Combined Precapillary and Postcapillary Pulmonary Hypertension: Results From PADN-5 Trial.
    JACC Heart Fail. 2023 Jun 12:S2213-1779(23)00252.
    PubMed    
    Abstract available

  30. ANDRASKA EA, Bonaroti J, Zhang Y, Rivera-Lebron B, et al
    Predictors of Chronic Thromboembolic Pulmonary Hypertension in patients with Submassive Pulmonary Embolism treated with catheter directed thrombolysis versus anticoagulation alone: a secondary analysis of the SUNSET sPE trial.
    J Vasc Surg Venous Lymphat Disord. 2023 Jun 21:S2213-333X(23)00235.
    PubMed    
    Abstract available

  31. ZHAO Q, Zhang R, Shi J, Xie H, et al
    Imaging Features in BMPR2 Mutation-associated Pulmonary Arterial Hypertension.
    Radiology. 2023 May 16:222488. doi: 10.1148/radiol.222488.
    PubMed    
    Abstract available

  32. WANG J, Zhang Y, Luo Y, Liu ML, et al
    PDK1 upregulates PINK1-mediated pulmonary endothelial cell mitophagy during hypoxia-induced pulmonary vascular remodeling.
    Mol Biol Rep. 2023;50:5585-5596.
    PubMed    
    Abstract available

  33. GUGLIN M, Kozaily E, Kittleson MM
    Choosing wisely: incorporating appropriate donor-recipient size matching in heart transplantation.
    Heart Fail Rev. 2023;28:967-975.
    PubMed    
    Abstract available

  34. PRICE KW, Nguyen K, Lin P
    A 48-YEAR-OLD WOMAN WITH CHRONIC, PROGRESSIVE BILATERAL VISION LOSS AND DYSPNEA.
    Retin Cases Brief Rep. 2023;17.
    PubMed    
    Abstract available

  35. DINI FL, Pugliese NR, Ameri P, Attanasio U, et al
    Right ventricular failure in left heart disease: from pathophysiology to clinical manifestations and prognosis.
    Heart Fail Rev. 2023;28:757-766.
    PubMed    
    Abstract available

  36. SHIMOKAWAHARA H, Inami T, Kubota K, Taniguchi Y, et al
    Protocol for a multicentre, double-blind, randomised, placebo-controlled trial of riociguat on peak cardiac index during exercise in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty (THERAPY-HYBRID-BPA tr
    BMJ Open. 2023;13:e072241.
    PubMed    
    Abstract available

  37. MORGAN RW, Reeder RW, Ahmed T, Bell MJ, et al
    Outcomes and Characteristics of Cardiac Arrest in Children with Pulmonary Hypertension: A Secondary Analysis of the ICU-RESUS Clinical Trial.
    Resuscitation. 2023 Jul 3:109897. doi: 10.1016/j.resuscitation.2023.109897.
    PubMed    
    Abstract available

  38. LANG IM
    Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Clinical Outcomes.
    Eur Cardiol. 2023;18:e11.
    PubMed    
    Abstract available

  39. ZEIGER E, Jakob A, Dalla Pozza R, Fischer M, et al
    Evaluation of the diagnostic and prognostic potential of optical coherence tomography (OCT) of the pulmonary arteries during standardised right heart catheterisation in patients with pulmonary hypertension: a cross-sectional single-centre experience.
    Cardiovasc Diagn Ther. 2023;13:453-464.
    PubMed    
    Abstract available

  40. SIMPSON CE, Ambade AS, Harlan R, Roux A, et al
    Spatial and temporal resolution of metabolic dysregulation in the Sugen hypoxia model of pulmonary hypertension.
    Pulm Circ. 2023;13:e12260.
    PubMed    
    Abstract available

  41. CASTRO MF, Oliveira EC, Nunes MCP, Oliveira C, et al
    Reverse Potts for the Treatment of Severe Idiopathic Pulmonary Hypertension in Children.
    Braz J Cardiovasc Surg. 2023;38:e20220320.
    PubMed    
    Abstract available

  42. TA HT, Critser PJ, Schafer M, Ollberding NJ, et al
    Ventricular global function index is associated with clinical outcomes in pediatric pulmonary hypertension.
    J Cardiovasc Magn Reson. 2023;25:39.
    PubMed    
    Abstract available

  43. FENG X, Yang C, Sun Z, Kan W, et al
    Risk factors for mortality in patients with acute exacerbation of cor pulmonale in plateau.
    BMC Pulm Med. 2023;23:238.
    PubMed    
    Abstract available

  44. THOMAS S, Jain S, Murthy P, Joseph CJ, et al
    Neurodevelopmental Outcomes of Preterm Infants Born <29 weeks with Bronchopulmonary Dysplasia Associated Pulmonary Hypertension: A Multicenter Study.
    Am J Perinatol. 2023 Jul 3. doi: 10.1055/a-2121-8878.
    PubMed    
    Abstract available

  45. MAO M, Song S, Li X, Lu J, et al
    Advances in epigenetic modifications of autophagic process in pulmonary hypertension.
    Front Immunol. 2023;14:1206406.
    PubMed    
    Abstract available

  46. FAWZY A, Mafeld S, Oreopoulos G, de Perrot M, et al
    Chronic thromboembolic pulmonary hypertension secondary to a vascular malformation: case report diagnosis by lung subtraction iodine mapping.
    Front Med (Lausanne). 2023;10:1206116.
    PubMed    
    Abstract available

  47. ZHAO Y, Wu J, Guan S, Xue T, et al
    PIF1 Promotes Autophagy to Inhibit Chronic Hypoxia Induced Apoptosis of Pulmonary Artery Endothelial Cells.
    Int J Chron Obstruct Pulmon Dis. 2023;18:1319-1332.
    PubMed    
    Abstract available

  48. JUSTIN PAUL G, Anne Princy S, Anju S, Anita S, et al
    Pregnancy outcomes in women with heart disease: the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India.
    Eur Heart J. 2023;44:1530-1540.
    PubMed    
    Abstract available

  49. WANG D, Luo MY, Tian Y, Zhang J, et al
    Critical miRNAs in regulating pulmonary hypertension: A focus on Signaling pathways and therapeutic Targets.
    Anal Biochem. 2023 Jun 30:115228. doi: 10.1016/j.ab.2023.115228.
    PubMed    
    Abstract available

  50. POKHAREL MD, Marciano DP, Fu P, Franco MC, et al
    Metabolic reprogramming, oxidative stress, and pulmonary hypertension.
    Redox Biol. 2023;64:102797.
    PubMed    
    Abstract available

  51. WANG G, Qin J, Han D
    Long-term safety of macitentan in patients with pulmonary hypertension: A meta-analysis of randomised controlled trials.
    Eur J Clin Invest. 2023 Jul 1:e14059. doi: 10.1111/eci.14059.
    PubMed    
    Abstract available

  52. ESCARCEGA RO, Lopez-Mattei J
    Editorial: The importance of RV-PA coupling assessment prior to TAVR in patients with RV dysfunction and pulmonary hypertension.
    Cardiovasc Revasc Med. 2023 Jun 25:S1553-8389(23)00670.
    PubMed    


  53. AHMAD M, Del Cid Fratti J, Henien M, Pant K, et al
    Association Between Pulmonary Hypertension and Its Effect on 30-Day Mortality, Readmission, and Cost After Transcatheter Aortic Valve Replacement: A Multicenter Study.
    Cureus. 2023;15:e40976.
    PubMed    
    Abstract available

  54. MAINI A, Cousins S, Holliday T, Memoli JW, et al
    Hemoptysis: unilateral pulmonary artery atresia? a case report.
    J Cardiothorac Surg. 2023;18:199.
    PubMed    
    Abstract available

  55. ANDERSEN MO, Diederichsen SZ, Svendsen JH, Carlsen J, et al
    Continuous long-term heart rate variability and risk assessment in pulmonary hypertension.
    Open Heart. 2023;10:e002302.
    PubMed    
    Abstract available

  56. HAN QJ, Forfia P, Vaidya A, Ramani G, et al
    Effects of ranolazine on right ventricular function, fluid dynamics, and metabolism in patients with precapillary pulmonary hypertension: insights from a longitudinal, randomized, double-blinded, placebo controlled, multicenter study.
    Front Cardiovasc Med. 2023;10:1118796.
    PubMed    
    Abstract available

  57. FORTMEIER V, Lachmann M, Rudolph V
    Reply: Right Ventricular-Pulmonary Arterial Coupling: So You Think You Can Tell?
    JACC Cardiovasc Interv. 2023;16:1550.
    PubMed    


  58. FORTUNI F, Ciliberti G, Zilio F
    Right Ventricular-Pulmonary Arterial Coupling: So You Think You Can Tell.
    JACC Cardiovasc Interv. 2023;16:1549.
    PubMed    


  59. AMANN U, Nadine Wentzell, Kollhorst B, Haug U, et al
    Prescribing of endothelin receptor antagonists and riociguat in women of childbearing age in a large German claims database study.
    Reprod Toxicol. 2023;119:108415.
    PubMed    
    Abstract available

  60. NOH CY, Chock VY, Bhombal S, Danzer E, et al
    Early nitric oxide is not associated with improved outcomes in congenital diaphragmatic hernia.
    Pediatr Res. 2023 Feb 1. doi: 10.1038/s41390-023-02491.
    PubMed    
    Abstract available

  61. NEKOOEIAN M, Ezzatzadegan Jahromi S, Masjedi F, Sohooli M, et al
    The significance of volume overload in the development of pulmonary arterial hypertension in continuous ambulatory peritoneal dialysis patients.
    Ther Apher Dial. 2023;27:760-770.
    PubMed    
    Abstract available

  62. WU X, Li J, Ma J, Liu Q, et al
    Vaccination against coronavirus disease 2019 in patients with pulmonary hypertension: a national prospective cohort study.
    Chin Med J (Engl). 2023 Jul 13. doi: 10.1097/CM9.0000000000002767.
    PubMed    
    Abstract available

  63. WANG Y, Zeng Z, Zeng Z, Chu G, et al
    Elevated CHCHD4 orchestrates mitochondrial oxidative phosphorylation to disturb hypoxic pulmonary hypertension.
    J Transl Med. 2023;21:464.
    PubMed    
    Abstract available

  64. WANG E, Zhou S, Zeng D, Wang R, et al
    Molecular regulation and therapeutic implications of cell death in pulmonary hypertension.
    Cell Death Discov. 2023;9:239.
    PubMed    
    Abstract available

  65. LE DUC K, Rakza T, Baudelet JB, Boukhris MR, et al
    Diastolic ventricular function in persistent pulmonary hypertension of the newborn.
    Front Pediatr. 2023;11:1175178.
    PubMed    
    Abstract available

  66. GAVOTTO A, Amedro P, Cambonie G
    Think out of the box: association of left congenital diaphragmatic hernia and abnormal origin of the right pulmonary artery : A train can hide another.
    BMC Pediatr. 2023;23:349.
    PubMed    
    Abstract available

  67. HEMMATI F, Barzegar H
    Persistent pulmonary hypertension of the newborn due to methylmalonic acidemia: a case report and review of the literature.
    J Med Case Rep. 2023;17:288.
    PubMed    
    Abstract available

  68. DONG TX, Zhu Q, Wang ST, Wang YH, et al
    Diagnostic and prognostic value of echocardiography in pulmonary hypertension: an umbrella review of systematic reviews and meta-analyses.
    BMC Pulm Med. 2023;23:253.
    PubMed    
    Abstract available

  69. DU D, Yuan YD
    Efficacy and safety of macitentan for pulmonary hypertension: A meta-analysis.
    Clin Respir J. 2023 Jul 10. doi: 10.1111/crj.13621.
    PubMed    
    Abstract available

  70. MILES KG, Critser PJ, Evers PD, Cash M, et al
    Factors leading to supranormal cardiac index in pediatric pulmonary hypertension patients treated with parenteral prostanoid therapy.
    Pulm Circ. 2023;13:e12264.
    PubMed    
    Abstract available

  71. VAN GENECHTEN S, Meyns B, Godinas L, Maleux G, et al
    Anthracofibrosis mimicking chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2023;13:e12263.
    PubMed    
    Abstract available

  72. PISTELLI L, Piccione MC, Parisi F, Di Bella G, et al
    Rapid Onset Idiopathic Pulmonary Hypertension: A Case Report with a Review of Echocardiographic Parameters.
    J Cardiovasc Echogr. 2023;33:43-48.
    PubMed    
    Abstract available

  73. ZHENG L, Tan J, Yan Y, Wang S, et al
    Retrospective on global pulmonary hypertension clinical trials: 1999-2021.
    J Thorac Dis. 2023;15:3372-3385.
    PubMed    
    Abstract available

  74. SINGH H, Agarwal L, Jani C, Bhatt P, et al
    Pulmonary hypertension associated mortality in the United States from 2003 to 2020: an observational analysis of time trends and disparities.
    J Thorac Dis. 2023;15:3256-3272.
    PubMed    
    Abstract available

  75. SCHUSSLER A, Lug Q, Kremer N, Harth S, et al
    Evaluation of diagnostic accuracy of dual-energy computed tomography in patients with chronic thromboembolic pulmonary hypertension compared to V/Q-SPECT and pulmonary angiogram.
    Front Med (Lausanne). 2023;10:1194272.
    PubMed    
    Abstract available

  76. LI B, Teng C, Yu H, Jiang X, et al
    Alleviating experimental pulmonary hypertension via co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries.
    Acta Pharm Sin B. 2023;13:2369-2382.
    PubMed    
    Abstract available

  77. RENAPURKAR RD, Bullen J, Rizk A, Abozeed M, et al
    A Novel Dual Energy Computed Tomography Score Correlates With Postoperative Outcomes in Chronic Thromboembolic Pulmonary Hypertension.
    J Thorac Imaging. 2023 Jul 7. doi: 10.1097/RTI.0000000000000724.
    PubMed    
    Abstract available

  78. CHO S, Oh SB, Kim HJ, Kim SJ, et al
    T18/S19 diphosphorylation of myosin regulatory light chain impairs pulmonary artery relaxation in monocrotaline-induced pulmonary hypertensive rats.
    Pflugers Arch. 2023 Jul 8. doi: 10.1007/s00424-023-02836.
    PubMed    
    Abstract available

  79. MAJEED H, Cannon B, Raj K, Nasrullah A, et al
    COVID-19 Patients with Pulmonary Hypertension Hospitalized in the United States During the Early Pandemic: Analysis of In-Hospital Mortality, Clinical Outcomes, and Racial Disparities.
    Curr Probl Cardiol. 2023 Jul 7:101933. doi: 10.1016/j.cpcardiol.2023.101933.
    PubMed    
    Abstract available

  80. ARONSON K, Jacobs SS, Repola D, Swigris JJ, et al
    Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?
    BMJ Open Respir Res. 2023;10:e001546.
    PubMed    
    Abstract available

  81. FOX TH, LaNasa M, Saketkoo LA, Saito S, et al
    STOP-Bang for OSA screening in patients with pulmonary hypertension.
    Respir Med. 2023;217:107339.
    PubMed    


  82. OMER KA, Mlauzi R, Basera W, McGuire J, et al
    Low incidence of pulmonary hypertension in children with suspected obstructive sleep apnea: A prospective observational study.
    Int J Pediatr Otorhinolaryngol. 2023;171:111648.
    PubMed    
    Abstract available

  83. METHODS IN MEDICINE CAM
    Retracted: The Levels of TNF-alpha, Tissue Factor, and Coagulation Function in Rats with Pulmonary Hypertension and the Intervention Effect of Sildenafil Encapsulated by Targeted Nanocarriers.
    Comput Math Methods Med. 2023;2023:9805127.
    PubMed    
    Abstract available

  84. CARR H, Gunnerbeck A, Eisenlauer P, Johansson S, et al
    Severity of preterm birth and the risk of pulmonary hypertension in childhood: A population-based cohort study in Sweden.
    Paediatr Perinat Epidemiol. 2023 Jul 6. doi: 10.1111/ppe.12997.
    PubMed    
    Abstract available

  85. BERGMANN LL, Ackman JB, Starekova J, Moeller A, et al
    MR Angiography of Pulmonary Vasculature.
    Magn Reson Imaging Clin N Am. 2023;31:475-491.
    PubMed    
    Abstract available

  86. KAZMIRCZAK F, Prisco SZ, Knoper R, Huddleston S, et al
    Effect of Combination of Balloon Pulmonary Angioplasty and Medical Therapy on Reverse Right Ventricular Remodeling and Hemodynamics in Chronic Thromboembolic Pulmonary Hypertension.
    J Invasive Cardiol. 2023;35:E312-E320.
    PubMed    
    Abstract available

  87. ATZENI IM, Al-Adwi Y, Doornbos-van der Meer B, Roozendaal C, et al
    The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis.
    Front Immunol. 2023;14:1189257.
    PubMed    
    Abstract available

  88. ZHENG R, Xu T, Lin Y, Huang X, et al
    Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?
    Cardiovasc Res. 2023;119:e140-e141.
    PubMed    


  89. RODOR J, Chen SH, Baker AH
    Response to: Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?
    Cardiovasc Res. 2023;119:e142-e143.
    PubMed    


  90. ISHIDA S, Nakanishi H, Kosaka Y, Yamaguchi A, et al
    Evaluation of newborns with Down syndrome with weight less than 1500 g in the neonatal intensive care unit: A Japanese multicentre study.
    J Paediatr Child Health. 2023 Apr 28. doi: 10.1111/jpc.16418.
    PubMed    
    Abstract available

  91. THOMPSON WS, Bendel-Stenzel EM, Lanpher BC, Arteaga GM, et al
    Neonatal Diagnosis of Alveolar Capillary Dysplasia via Rapid Genomic Sequencing: A New Gold Standard?
    Neonatology. 2023 Mar 21:1-5. doi: 10.1159/000529439.
    PubMed    
    Abstract available

  92. BODENBERGER AL, Konietzke P, Weinheimer O, Wagner WL, et al
    Quantification of airway wall contrast enhancement on virtual monoenergetic images from spectral computed tomography.
    Eur Radiol. 2023;33:5557-5567.
    PubMed    
    Abstract available

  93. MARQUEZ MF
    Editorial commentary: The heart at high altitude.
    Trends Cardiovasc Med. 2023;33:316-318.
    PubMed    


  94. ARMAGAN B, Oksul M, Sener YZ, Sari A, et al
    Pulmonary hypertension in Behcet's disease: echocardiographic screening and multidisciplinary approach.
    Turk J Med Sci. 2023;53:563-571.
    PubMed    
    Abstract available

  95. AWAD AK, Gad ER, Abdelgalil MS, Elsaeidy AS, et al
    Sildenafil for congenital heart diseases induced pulmonary hypertension, a meta-analysis of randomized controlled trials.
    BMC Pediatr. 2023;23:372.
    PubMed    
    Abstract available

  96. YUCEL IK, Epcacan S, Bulut MO, Demir IH, et al
    A Challenging Interventional Procedure: Transcatheter Closure of Tubular Patent Ductus Arteriosus in Patients with Pulmonary Hypertension.
    Pediatr Cardiol. 2023 Jul 20. doi: 10.1007/s00246-023-03240.
    PubMed    
    Abstract available

  97. AYAN G, Sari A, Ardali Duzgun S, Kaya EB, et al
    Could pulmonary arterial hypertension-specific agents be an option for Takayasu's arteritis related pulmonary hypertension?
    Clin Exp Rheumatol. 2023 Jul 5. doi: 10.55563.
    PubMed    


  98. LANG IM, Andreassen AK, Andersen A, Bouvaist H, et al
    Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function.
    Eur Heart J. 2023 Jul 20:ehad413. doi: 10.1093.
    PubMed    
    Abstract available

  99. YILDIRIM S
    Inhaled iloprost is an effective alternative therapy for persistent pulmonary hypertension in newborns.
    Pulm Circ. 2023;13:e12268.
    PubMed    
    Abstract available

  100. GOTO S, Goto S
    Long-term outcome of chronic thromboembolic pulmonary hypertension in the era where direct oral anticoagulants become available.
    J Thromb Haemost. 2023;21:2058-2060.
    PubMed    


  101. WEST N, Smoot K, Patzlaff N, Miceli M, et al
    Plain language summary of the INCREASE study: inhaled treprostinil (Tyvaso) for the treatment of pulmonary hypertension due to interstitial lung disease.
    Future Cardiol. 2023 Jul 19. doi: 10.2217/fca-2022-0108.
    PubMed    
    Abstract available

  102. YAGMUR B, Simsek E, Kayikcioglu M, Yuce EI, et al
    Could Impedance Cardiography be a Non-Invasive Alternative Method of Measuring Cardiac Output in Patients with Pulmonary Hypertension?
    Anatol J Cardiol. 2023 Jul 19. doi: 10.14744/AnatolJCardiol.2023.2820.
    PubMed    
    Abstract available

  103. DENIWAR A, Hernandez J, Aregullin EO, Khan SK, et al
    Atrial septal defect-associated pulmonary hypertension with decompensated heart failure: outcomes after fenestrated device closure.
    Cardiol Young. 2023 Jul 19:1-6. doi: 10.1017/S104795112300152.
    PubMed    
    Abstract available

  104. DAVE J, Jagana V, Janostiak R, Bisserier M, et al
    Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development.
    J Transl Med. 2023;21:477.
    PubMed    
    Abstract available

  105. KONDO T, Fujiwara K, Nakagawa M, Fujimoto K, et al
    Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients.
    Sci Rep. 2023;13:11524.
    PubMed    
    Abstract available

  106. SONG JR, Zhang JW, Li B, Deng MJ, et al
    [Pulmonary arterial hypertension in a pedigree with bone morphogenetic protein receptor 2 c.282 mutation].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2023;51:769-772.
    PubMed    


  107. CHIVERS S, Cleary A, Knowles R, Babu-Narayan SV, et al
    COVID-19 in congenital heart disease (COaCHeD) study.
    Open Heart. 2023;10:e002356.
    PubMed    
    Abstract available

  108. WANG Y, Tan YP, Zhang L, Zheng LN, et al
    Application of lung ultrasound in monitoring bronchopulmonary dysplasia and pulmonary arterial pressure in preterm infants.
    Eur Rev Med Pharmacol Sci. 2023;27:5964-5972.
    PubMed    
    Abstract available

  109. GOPALRATNAM K, Odeyemi Y, Del Valle KT, Frank RD, et al
    Characteristics and Outcomes of Critically Ill Patients With Pulmonary Hypertension Who Undergo Endotracheal Intubation and Mechanical Ventilation.
    J Intensive Care Med. 2023 Jul 16:8850666231186761.
    PubMed    
    Abstract available

  110. NEWMAN A, D'Souza SL
    Patient-Friendly Summary of the ACR Appropriateness Criteria(R): Suspected Pulmonary Hypertension.
    J Am Coll Radiol. 2023 Jul 4:S1546-1440(23)00417.
    PubMed    


  111. BENZIDIA I, Robitaille C, Abualsaud A, McDonald L, et al
    Safety and efficacy of direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2023;229:139-145.
    PubMed    
    Abstract available

  112. ZHANG ZJ, Wang HF, Lian TY, Zhou YP, et al
    Human Plasma IgG N-Glycome Profiles Reveal a Proinflammatory Phenotype in Chronic Thromboembolic Pulmonary Hypertension.
    Hypertension. 2023 Jul 14. doi: 10.1161/HYPERTENSIONAHA.123.21408.
    PubMed    
    Abstract available

  113. XU WJ, Wu Q, He WN, Wang S, et al
    Interleukin-6 and pulmonary hypertension: from physiopathology to therapy.
    Front Immunol. 2023;14:1181987.
    PubMed    
    Abstract available

  114. JIANG CY, Wu LW, Liu YW, Feng B, et al
    Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension.
    Front Immunol. 2023;14:1153573.
    PubMed    
    Abstract available

  115. LI Y, Chen Y, Yang L, Li Y, et al
    Increased plasma expression of a disintegrin and metalloproteinase with thrombospondin motifs like 4 in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2023;13:e12267.
    PubMed    
    Abstract available

  116. GRANOT Y, Ziv-Baran T, Berliner S, Topilsky Y, et al
    Left atrium volume and ventricular volume ratio algorithm as indication of pulmonary hypertension etiology.
    Acta Radiol. 2023 Jul 13:2841851231187065. doi: 10.1177/02841851231187065.
    PubMed    
    Abstract available

  117. LEY L, Wiedenroth CB, Ghofrani HA, Hoeltgen R, et al
    Analysis of Electrocardiographic Criteria of Right Ventricular Hypertrophy in Patients with Chronic Thromboembolic Pulmonary Hypertension before and after Balloon Pulmonary Angioplasty.
    J Clin Med. 2023;12:4196.
    PubMed    
    Abstract available

  118. JONAS K, Kurzyna M, Mroczek E, Chrzanowski L, et al
    Impact of diabetes mellitus on disease severity and patient survival in idiopathic pulmonary arterial hypertension: data from the Polish multicentre registry (BNP-PL).
    Cardiovasc Diabetol. 2023;22:177.
    PubMed    
    Abstract available

  119. KASAVI C
    Idiopathic Pulmonary Arterial Hypertension: Network-Based Integration of Multi-Omics Data Reveals New Molecular Signatures and Candidate Drugs.
    OMICS. 2023;27:315-326.
    PubMed    
    Abstract available

  120. COCIANNI D, Stolfo D, Perotto M, Contessi S, et al
    Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure.
    Circ Cardiovasc Imaging. 2023 Jun 29:e014988.
    PubMed    
    Abstract available

  121. ZHANG R, Zhang J, Zhang YL, Gong SG, et al
    Single-Cell Transcriptome Analysis of Peripheral Neutrophils From Patients With Idiopathic Pulmonary Arterial Hypertension.
    Hypertension. 2023 Jun 14. doi: 10.1161/HYPERTENSIONAHA.123.21142.
    PubMed    
    Abstract available

  122. GARCIA MVF, Coz-Yataco A, Al-Jaghbeer MJ
    Pulmonary arterial hypertension trials put to the test: Using the fragility index to assess trials robustness.
    Heart Lung. 2023;61:147-152.
    PubMed    
    Abstract available

  123. DOGGRELL SA
    Is sotatercept, which traps activins and growth differentiation factors, a new dawn in treating pulmonary arterial hypertension (PAH)?
    Expert Opin Biol Ther. 2023;23:589-593.
    PubMed    
    Abstract available

  124. CHOMETTE L, Hupkens E, Romitti M, Dewachter L, et al
    Pediatric pulmonary arterial hypertension due to a novel homozygous GDF2 missense variant affecting BMP9 processing and activity.
    Am J Med Genet A. 2023;191:2064-2073.
    PubMed    
    Abstract available

  125. DAY RW, Lai KV, Baisch HN, Lau IC, et al
    Descriptive images and features of pulmonary vascular disease in a child with a FOXF1 variant.
    Pediatr Pulmonol. 2023;58:2383-2385.
    PubMed    


  126. FRITZ AS, Keller T, Kribs A, Hunseler C, et al
    Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life.
    Eur J Pediatr. 2023 Apr 18. doi: 10.1007/s00431-023-04973.
    PubMed    
    Abstract available

  127. IACONELLI A, Cuthbert J, Kazmi S, Maffia P, et al
    Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity.
    Clin Res Cardiol. 2023;112:1077-1086.
    PubMed    
    Abstract available

  128. METHODS IN MEDICINE CAM
    Retracted: HMGB1 Upregulates RAGE to Trigger the Expression of Inflammatory Factors in the Lung Tissue in a Hypoxic Pulmonary Hypertension Rat Model.
    Comput Math Methods Med. 2023;2023:9830545.
    PubMed    
    Abstract available

  129. FINSTERER J
    Confusion in connection with pulmonary hypertension due to premature ventricular complexes requires diagnostic work-up.
    Eur Heart J Case Rep. 2023;7:ytad281.
    PubMed    


  130. LUANI B, Wiemer M, Braun-Dullaeus RC
    Confusion in connection with pulmonary hypertension due to premature ventricular complexes requires diagnostic work-up.
    Eur Heart J Case Rep. 2023;7:ytad321.
    PubMed    


  131. BASHIR R, Noory A, Oliveros E, Romero C, et al
    Refined Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: Initial Results of U.S. Regional Program.
    JACC Adv. 2023;2:100291.
    PubMed    
    Abstract available

  132. ALERHAND S, Adrian RJ
    What echocardiographic findings differentiate acute pulmonary embolism and chronic pulmonary hypertension?
    Am J Emerg Med. 2023;72:72-84.
    PubMed    
    Abstract available

  133. SALINAS CE, Patey OV, Murillo C, Gonzales M, et al
    Preeclampsia and risk of maternal pulmonary hypertension at high altitude in Bolivia.
    J Dev Orig Health Dis. 2023 Jul 27:1-9. doi: 10.1017/S2040174423000193.
    PubMed    
    Abstract available

  134. PLECITA-HLAVATA L, Brazdova A, Krivonoskova M, Hu CJ, et al
    Microenvironmental regulation of T-cells in pulmonary hypertension.
    Front Immunol. 2023;14:1223122.
    PubMed    
    Abstract available

  135. KARMOUTY-QUINTANA H
    Correction to "Inhibition of hyaluronan synthesis attenuates pulmonary hypertension associated with lung fibrosis".
    Br J Pharmacol. 2023 Jul 25. doi: 10.1111/bph.16194.
    PubMed    


  136. ALABDALJABAR MS, Naser JA, Kane CJ, Lara-Breitinger KM, et al
    Tricuspid Regurgitation Impact on Outcomes (TRIO) score for risk stratification in patients with pulmonary hypertension.
    J Am Soc Echocardiogr. 2023 Jul 23:S0894-7317(23)00364.
    PubMed    


  137. WESSELS JN, Celant LR, de Man FS, Noordegraaf AV, et al
    The Right Ventricle in Pulmonary Hypertension.
    Semin Respir Crit Care Med. 2023 Jul 24. doi: 10.1055/s-0043-1770117.
    PubMed    
    Abstract available

  138. TORBICKI A, Kurzyna M
    The Diagnostic Approach to Pulmonary Hypertension.
    Semin Respir Crit Care Med. 2023 Jul 24. doi: 10.1055/s-0043-1770116.
    PubMed    
    Abstract available

  139. BLANCO I, Hernandez-Gonzalez F, Garcia A, Torres-Castro R, et al
    Management of Pulmonary Hypertension Associated with Chronic Lung Disease.
    Semin Respir Crit Care Med. 2023 Jul 24. doi: 10.1055/s-0043-1770121.
    PubMed    
    Abstract available

  140. YANG H, Cao J, Li JM, Li C, et al
    Exploration of the molecular mechanism of tea polyphenols against pulmonary hypertension by integrative approach of network pharmacology, molecular docking, and experimental verification.
    Mol Divers. 2023 Jul 24. doi: 10.1007/s11030-023-10700.
    PubMed    
    Abstract available

  141. OZTURK SAHIN B, Galata Z, Demir S, Yilmaz Demirci N, et al
    Granulomatous Mediastinitis: A Rare Cause of Pulmonary Hypertension.
    Thorac Res Pract. 2023;24:231-234.
    PubMed    
    Abstract available

  142. THENAPPAN T, Gomberg-Maitland M
    Pulmonary Artery Denervation for Combined Pre- and Post-Capillary Pulmonary Hypertension: Hype or Hope?
    JACC Heart Fail. 2023 Jul 8:S2213-1779(23)00331.
    PubMed    


  143. KUCHERENKO MM, Sang P, Yao J, Gransar T, et al
    Elastin stabilization prevents impaired biomechanics in human pulmonary arteries and pulmonary hypertension in rats with left heart disease.
    Nat Commun. 2023;14:4416.
    PubMed    
    Abstract available

  144. SAVEETA F, Payal F, Bai Bansari R
    Comment on "Riociguat and Balloon Pulmonary Angioplasty Improve Prognosis in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension".
    Curr Probl Cardiol. 2023 Jul 19:101967. doi: 10.1016/j.cpcardiol.2023.101967.
    PubMed    


  145. DYESS NF, Palmer C, Soll RF, Clark RH, et al
    Practices and Outcomes from a Prospective, Multicenter Registry for Preterm Newborns with Pulmonary Hypertension.
    J Pediatr. 2023 Jul 19:113614. doi: 10.1016/j.jpeds.2023.113614.
    PubMed    
    Abstract available

  146. LUO Y, Gordon J, Xu J, Kolstad KD, et al
    Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry.
    Rheumatology (Oxford). 2023 Jul 21:kead368. doi: 10.1093.
    PubMed    
    Abstract available

  147. ORIHARA Y, Asakura M, Min KD, Matsumoto Y, et al
    Mean pulmonary artery pressure estimated by echocardiogram rapidly exceeds 20 mmHg from the normal range in patients with connective tissue disease.
    Heart Vessels. 2023;38:1172-1180.
    PubMed    
    Abstract available

  148. MA J, Luo F, Yan L
    Neonatal outcomes in pregnant women with pulmonary arterial hypertension associated with heart disease.
    Pediatr Neonatol. 2023;64:450-454.
    PubMed    
    Abstract available

  149. HARINSTEIN ME, Rajaratnam A
    Enhancing Detection of Pulmonary Hypertension: A Screening Tool to Quickly Identify and Refer Patients.
    Am J Cardiol. 2023 Jul 25:S0002-9149(23)00565.
    PubMed    


  150. ONI OO, Odeyemi AO, Olasinde YT, Odeyemi AO, et al
    Pulmonary Hypertension and Left Ventricular Geometric Types in Sickle Cell Anemia.
    Am J Cardiol. 2023;203:175-183.
    PubMed    
    Abstract available

  151. MCNAIR BD, Polson SM, Shorthill SK, Yusifov A, et al
    Metformin protects against pulmonary hypertension-induced right ventricular dysfunction in an age- and sex-specific manner independent of cardiac AMPK.
    Am J Physiol Heart Circ Physiol. 2023 Jun 30. doi: 10.1152/ajpheart.00124.2023.
    PubMed    
    Abstract available

  152. LEIVA O, Garcia BD, Hobbs G
    Pulmonary Hypertension in Myeloproliferative Neoplasms: New Insights and Unexplored Horizons.
    Am J Respir Crit Care Med. 2023 Jul 10. doi: 10.1164/rccm.202306-1001.
    PubMed    


  153. JOHNSON S, Sommer N, Cox-Flaherty K, Weissmann N, et al
    Pulmonary Hypertension: A Contemporary Review.
    Am J Respir Crit Care Med. 2023 Jul 14. doi: 10.1164/rccm.202302-0327.
    PubMed    
    Abstract available

  154. YAMAGUCHI CT, Moody AE, Beutler BD, Lee JP, et al
    Severe Pulmonary Hypertension and Septum Left Shift.
    Anesthesiology. 2023 Jul 12. doi: 10.1097/ALN.0000000000004638.
    PubMed    


  155. KABADI AA, Fernandes TM, Papamatheakis DG, Poch DS, et al
    Airway Hemorrhage Complicating Pulmonary Thromboendarterectomy: Risk Factors and Outcomes.
    Ann Thorac Surg. 2023;116:121-128.
    PubMed    
    Abstract available

  156. CARBONE RG, Monselise A, Puppo F
    Treprostinil and Clinical Outcome in Pulmonary Hypertension and Interstitial Lung Disease: Is All Clear?
    Chest. 2023;164:e21.
    PubMed    


  157. DUBROCK HM
    Portopulmonary Hypertension: Management and Liver Transplantation Evaluation.
    Chest. 2023;164:206-214.
    PubMed    
    Abstract available


  158. Correction to: Heteroplasmy of Wild-Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease With Pulmonary Hypertension and Frailty.
    Circulation. 2023;148:e2.
    PubMed    


  159. PICCARI L, Aguilar-Colindres R, Rodriguez-Chiaradia DA
    Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?
    Curr Opin Pulm Med. 2023 Jul 3. doi: 10.1097/MCP.0000000000000984.
    PubMed    
    Abstract available

  160. BAIR ND, Heresi GA
    Lessons learned in developing a chronic thromboembolic pulmonary hypertension program.
    Curr Opin Pulm Med. 2023 Jun 29. doi: 10.1097/MCP.0000000000000983.
    PubMed    
    Abstract available

  161. COTTIN V, Diesler R, Turquier S, Valenzuela C, et al
    Interstitial lung disease-associated pulmonary hypertension - what the future holds.
    Curr Opin Pulm Med. 2023 Jul 10. doi: 10.1097/MCP.0000000000000992.
    PubMed    
    Abstract available

  162. LABRADA L, Vaidy A, Vaidya A
    Right ventricular assessment in pulmonary hypertension.
    Curr Opin Pulm Med. 2023 Jul 7. doi: 10.1097/MCP.0000000000000980.
    PubMed    
    Abstract available

  163. FRANTZ RP
    Group 2 pulmonary hypertension: from diagnosis to treatment.
    Curr Opin Pulm Med. 2023 Jul 18. doi: 10.1097/MCP.0000000000001002.
    PubMed    
    Abstract available

  164. COTTIN V, Valenzuela C, Humbert M
    Inhaled treprostinil for interstitial lung disease-associated pulmonary hypertension: a silver lining on a very dark cloud.
    Eur Respir J. 2023;61:2300944.
    PubMed    


  165. WAXMAN A, Restrepo-Jaramillo R, Thenappan T, Engel P, et al
    Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study.
    Eur Respir J. 2023;61:2202414.
    PubMed    
    Abstract available

  166. PICCARI L, Blanco I, Torralba Y, Arismendi E, et al
    Mechanisms of hypoxaemia in severe pulmonary hypertension associated with COPD.
    Eur Respir J. 2023 Jul 6:2300463. doi: 10.1183/13993003.00463-2023.
    PubMed    


  167. YEH FC, Chen CN, Xie CY, Baxan N, et al
    TLR7/8 activation induces autoimmune vasculopathy and causes severe pulmonary arterial hypertension.
    Eur Respir J. 2023;62:2300204.
    PubMed    
    Abstract available

  168. KEARNEY K, Lau EM
    Pulmonary arterial compliance: a physiological variable still searching for clinical relevance?
    Heart. 2023;109:1052-1053.
    PubMed    


  169. CARDAIOLI F, Nai Fovino L, Fabris T, Masiero G, et al
    Updated definition of pulmonary hypertension and outcome after transcatheter aortic valve implantation.
    Heart. 2023 Jul 6:heartjnl-2023-322881. doi: 10.1136/heartjnl-2023-322881.
    PubMed    
    Abstract available

  170. CHAN JCY, Man HSJ, Asghar UM, McRae K, et al
    Impact of sex on outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2023 Jul 6:S1053-2498(23)01897.
    PubMed    
    Abstract available

  171. RAKO ZA, Yogeswaran A, Lakatos BK, Fabian A, et al
    Clinical and functional relevance of right ventricular contraction patterns in pulmonary hypertension.
    J Heart Lung Transplant. 2023 Jul 12:S1053-2498(23)01935.
    PubMed    
    Abstract available

  172. KITANO T, Nabeshima Y, Nagata Y, Takeuchi M, et al
    Prognostic value of the right ventricular ejection fraction using three-dimensional echocardiography: Systematic review and meta-analysis.
    PLoS One. 2023;18:e0287924.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.


;